AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMPAGLIFLOZINE
7 registrations across 3 African markets— 1 active
Markets with EMPAGLIFLOZINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| JARDIANCE-10 TABLETS | 🇷🇼Rwanda | Boehringer Ingelheim International GmbH | active | Aug 2029 |
| EMPAGLIFLOZINE OPALIA Comprimé pelliculé / 10 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Oct 2023 |
| EMPAGLIFLOZINE OPALIA Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Oct 2023 |
| EFLOZIN 25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PRIVATE) LIMITED | expired | Jan 2021 |
| EFLOZIN 10MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PRIVATE) LIMITED | expired | Jan 2021 |
| JARDIANCE Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | May 2018 |
| JARDIANCE Comprimé pelliculé / 10 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | May 2018 |
EMPAGLIFLOZINE in Africa — Regulatory Overview
EMPAGLIFLOZINE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 1 (14%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.